gt-02287
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 15, 2025 (NCT06732180)
Timeline
Indications
Studied for
Mechanism of action
- Glucocerebrosidase GBA1/GBA2MODULATOR
Glucocerebrosidase GBA1/GBA2 modulator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07280299 | Phase 2 | May 30, 2026 | Gain Therapeutics |
| NCT06732180 | Phase 1 | Jan 15, 2025 | Gain Therapeutics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Gain Therapeutics | For profit | 2 | 2 | 2 | 2025 |
1 organizations
Page 1 / 1